Home >> Laboratory Science

Print This Page

Jeff Boyd, Ph.D. Director, Curtis and Elizabeth Anderson Cancer Institute Member, Department of Laboratory Oncology Research Vice President, Oncology and Research, Memorial University Medical Center Professor, Departments of Obstetrics and Gynecology, Surgery, Internal Medicine, and Division of Basic Medical Science, Mercer University School of Medicine - Savannah Campus Assistant Dean for Research, Mercer University School of Medicine - Savannah Campus Distinguished Cancer Scholar, State of Georgia 912-350-1652 (phone) 912-350-1269 (fax) BoydJe1@memorialhealth.com

Research Focus
Molecular genetics of endometrial, ovarian, and breast cancers, with a special emphasis on hereditary predisposition.

Biography
Jeff Boyd, Ph.D., is the vice president of oncology and research at Memorial University Medical Center, and director of the Curtis and Elizabeth Anderson Cancer Institute* at Memorial University Medical Center. He has a national and international reputation as one of the leading scientists in the study of the molecular genetics of women’s cancers and was named a Distinguished Cancer Scholar by the Georgia Cancer Coalition. Boyd came to Savannah from Memorial Sloan-Kettering Cancer Center in New York City, where he served as an attending biologist and director of the gynecology and breast research laboratory in the Department of Surgery and director of the diagnostic molecular genetics laboratory in the Department of Medicine. Boyd earned his Bachelor of Science degree from Duke University and his Doctor of Philosophy at North Carolina State University. Throughout his career, Boyd has received more than 14 National Institutes of Health (NIH) or NIH-equivalent research grants totaling several million dollars. He has served on the editorial boards of five prestigious journals, including the American Journal of Pathology and the Journal of Clinical Oncology. Boyd has published more than 170 articles, reviews, and textbook chapters, and presented over 150 invited lectures nationally and internationally.

Recent Publications
King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Boyd J. BRCA haploinsufficiency in human breast tumorigenesis. Ann Surg Oncol. 2007; in press.

Black D, Soslow RA, Levine DA, Tornos C, Chen SC, Hummer AJ, Bogomolniy F, Olvera N, Barakat RR, Boyd J. The clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J. Clin Oncol. 2006;24:1745-1753.

Ferguson SE, Olshen AB, Viale A, Barakat RR, Boyd J. Stratification of intermediate risk endometrial cancer patients into groups at high- or low-risk for recurrence based on tumor gene expression profiles. Clin Cancer Res. 2005;11:2252-2257.

Jazaeri AA, Awtrey CS, Gadisetti CVR, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett CJ, Boyd J. Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers. Clin Cancer Res. 2005;11:6300-6310.

King TA, Gemignani ML, Li W, Tan LK, Giri DD, Panageas KS, Bogomolniy F, Arroyo C, Olvera N, Robson ME, Offit K, Borgen PI, Boyd J. Aberrant progesterone receptor expression in breast epithelium of BRCA1 mutation carriers. Cancer Res. 2004;64:5051-5053.

*The Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center is not affiliated with the University of Texas M.D. Anderson Cancer Center.